JP:4547 Stock Latest News
Company AnnouncementsKissei Lifts Interim Sales and Profit Outlook but Warns on Bottom Line Hit From TAVNEOS Charges3d ago
Company AnnouncementsKissei Faces Regulatory Scrutiny Over Rare-Disease Drug TAVNEOS in Japan1w ago
Company AnnouncementsKissei Pharmaceutical Advances Share Buyback Program on Tokyo Stock Exchange3w ago
Company AnnouncementsKissei Pharmaceutical Reports Progress on Share Buyback Program1M ago
Company AnnouncementsKissei Pharmaceutical Finalizes Adjusted Treasury Share Disposal for Employee Stock Plan2M ago
Company AnnouncementsKissei Pharmaceutical Reports No Treasury Share Purchases in July Under Ongoing Buyback Plan2M agoCompany AnnouncementsKissei Pharmaceutical Highlights Q1 FY2026 Results and R&D Pipeline Focus3M ago
Company AnnouncementsKissei Pharmaceutical Posts Mixed Q1 Results, Lifts Dividends but Cuts FY2027 Outlook3M ago
Pre-EarningsKissei Pharmaceutical Co (KSPHF) Q1 Earnings Cheat Sheet3M ago
Company AnnouncementsKissei Pharmaceutical Completes Treasury Share Disposal for Executive Restricted Stock3M ago- Company AnnouncementsKissei Pharmaceutical Reports No Share Buybacks Yet Under 2026 Repurchase Program4M ago
Company AnnouncementsKissei Faces EU Setback as EMA Backs Revocation of TAVNEOS Authorization4M agoCompany AnnouncementsKissei Pharmaceutical Grants Restricted Stock to Board Members and Officers4M ago
Company AnnouncementsKissei Pharmaceutical Sets Share Buyback Framework but Executes No Purchases in May5M ago
Company AnnouncementsKissei Files Japan NDA for IDH1-Targeting AML Drug Olutasidenib5M ago- Company AnnouncementsKissei Tightens Safety Warnings on TAVNEOS After Serious Liver Risk Cases5M ago
Company AnnouncementsKissei Restricts TAVNEOS Use in Japan After Global Safety and Data Concerns5M ago- Company AnnouncementsKissei Pharmaceutical Posts Record Sales as R&D Investment and Overseas Growth Intensify5M ago
Company AnnouncementsKissei Pharmaceutical Launches ¥6 Billion Share Buyback and Cancellation Plan5M agoCompany AnnouncementsKissei Pharmaceutical Details FY2026 Results and R&D Pipeline in Supplementary Report5M ago
Company AnnouncementsKissei Pharmaceutical Swings to Operating Loss but Lifts Payouts and Eyes Profit Recovery5M ago